Us News

FDA panel considers loosening regulations on certain unapproved peptides

The Food and Drug Administration advisory panel is holding a second day of meetings on whether to loosen restrictions on certain unapproved peptide drugs. The panel voted Thursday to broaden access to four peptides. KFF Health News' Amy Maxmen has more.

Published July 24, 2026, 4:53 PM
Updated July 24, 2026, 5:08 PM4.3K
FDA panel considers loosening regulations on certain unapproved peptides

The Food and Drug Administration advisory panel is holding a second day of meetings on whether to loosen restrictions on certain unapproved peptide drugs. The panel voted Thursday to broaden access to four peptides. KFF Health News' Amy Maxmen has more.

News17 is committed to delivering accurate, fair, and thoroughly researched reporting. If you believe this article contains an error, please contact our editorial team at corrections@news17.net. We take all reports seriously and will issue corrections promptly when warranted.